The fibrinolytic effects of intermittent pneumatic compression mechanism of enhanced fibrinolysis

Annals of Surgery

Volumn 226, Issue 3, 1997, Pages 306-314

  Comerota, Anthony J ^a,b,c   Chouhan, Vibhuti ^b   Harada, Russell N ^c   Sun, Ling ^b   Hosking, James ^a,b   Veermansunemi, Ravi ^a,c   Comerota Jr , Anthony J ^a   Schlappy, David ^a,b   Koneti Rao, A ^b  

^a Department of Surgery ^*  (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DEVICE; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; INTERMITTENT PNEUMATIC COMPRESSION; LEG COMPRESSION; MALE; PRIORITY JOURNAL;

ADULT; AGED; ALPHA-MACROGLOBULINS; ANTIPLASMIN; BIOLOGICAL MARKERS; COUNTERPULSATION; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRESSURE; THROMBOPHLEBITIS; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 0031419336     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199709000-00010     Document Type: Article

References (26)

1. NIH Consensus Development Statement. Prevention of venous thrombosis and pulmonary embolism. JAMA 1986; 256:744-749.
2. Clagett CP, Anderson FA, Heit J, et al. Prevention of venous thromboembolism. Chest 1995; 108:3125-3345.
3. Consensus Group. Prevention of venous thromboembolism: European consensus statement. Int Angiol 1992; 11:151-159.
4. Tarnay TJ, Rohr PR, Davidson AG, et al. Pneumatic calf compression, fibrinolysis, and the prevention of deep venous thrombosis. Surgery 1980; 88:489-496.
5. Salzman EW, McManama OP, Shaprio AH, et al. Effect of optimization on fibrinolytic activity and antithrombotic efficacy of external pneumatic calf compression. Ann Surg 1987; 206:636-641.
6. Jacobs DG, Piotrowski JJ, Hoppensteadt MA, et al. Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: preliminary results. J Trauma 1996; 40:710-717.
7. Francis CW, Marder VJ. Physiologic regulation and pathologic disorders of fibrinolysis. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis, Basic Principles and Clinical Practice. 3rd ed. Philadelphia: JB Lippincott Company; 1994; 1076-1103.
8. Prins MH, Hirsh J. A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism. Arch Intern Med 1991; 151:1721.
9. Clayton JK, Anderson JA, McNicol GP. Preoperative prediction of postoperative deep vein thrombosis. Br J Med 1976; 2:910-912.
10. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissuetype plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989; 79:101-106. '
11. Nicoloso G, Hauert J, Kruithof EKO, et al. Fibrinolysis in normal subjects-comparison between plasminogen activator inhibitor and other components of fibrinolytic system. Thromb Haemost 1988; 59:299-303.
12. Nilsson IM, Oloco B. Fibrinolysis induced by streptokinase in man. Acta Chir Scand 1962; 123:247-266.
13. Huynh H, Feldt LS. Conditions under which mean square ratios in repeated measurements designs have exact F-distributions. J Am Stat Assoc 1970; 65:1582-1589.
14. Davies MC, Hagen PO. The vascular endothelium, a new horizon. Ann Surg 1993; 218:593-609.
15. Eisenberg PR. Endothelial cell mediaters of thrombosis and fibrinolysis: review in depth. Coron Artery Dis 1991; 2:129-166.
16. Gertler JP, Abbott WM. Prothrombotic and fibrinolytic function of normal and perturbed endothelium. J Surg Res 1992; 52:89-92.
17. Mansfield AO. Alterations in fibrinolysis associated with surgery and venous thrombosis. Br J Surg 1972; 59:754-757.
18. Knight MTN, Dawson R, Melrose DG. Fibrinolytic response to surgery. Lancet 1977; 370-373.
19. Summaria MS, Caprini JA, McMillan R, et al. Relationship between postsurgical fibrinolytic parameters and deep vein thrombosis in surgical patients treated with compression devices. Am Surg 1988; 54:156-160.
20. Silver D. Discussion of: Tarnay TJ, Rohr PR, Davidson AG, et al. Pneumatic calf compression, fibrinolysis, and the prevention of deep venous thrombosis. Surgery 1980; 88:489-496.
21. Chandler WL, Trimble SL, Loo S-C, Mornin D. Effects of PAI-1 levels on the molar concentration of active tissue plasminogen activator (tPA) and tPA/PAI-1 complex in plasma. Blood 1990; 76:930-939.
22. Wiman B, Harnstein A. Impaired fibrinolysis and risk of thromboembolism. Prog Cardiovasc Dis 1991; 34:179-192.
23. Chouhan VC, Comerota AJ, Sun L, et al. Inhibition of tissue factor dependent pathway of blood coagulation following external pneumatic compression: a possible mechanism for antithrombotic effect. Blood 1996; 88:625a.
24. Hechtman HB. Prostaglandin and thromboxane mediation of cardiopulmonary failure. Surg Clin North Am 1983; 63:263-283.
25. Guyton DP, Khayat A, Schreiber H. Pneumatic compression stockings and prostacycline synthesis. Surg Gynecol Obstet 1988; 166:338-342.
26. Freiman JA, Chalmers TC, Smith H, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. N Engl J Med 1978; 299:690-694.